Super Agers: Unlocking the Genetic Secrets of Cognitive Resilience
Imagine living to 80 or older with cognitive abilities that rival those of someone 20 or 30 years younger. This is the phenomenon known as being a "super ager."
A groundbreaking study published in Alzheimer's & Dementia, The Journal of the Alzheimer's Association, reveals a fascinating insight into the genetic advantages of super agers. Researchers from Vanderbilt University Medical Center have discovered that super agers possess two key genetic benefits that may protect against late-onset Alzheimer's disease (AD).
The study focuses on a gene variant called APOE-ε4, which is known to significantly increase the risk of developing late-onset AD. Interestingly, another variant of the same gene, APOE-ε2, is believed to offer protection against AD. The researchers found that super agers have a remarkable advantage when it comes to these gene variants.
Super agers were 68% less likely to carry the APOE-ε4 variant compared to individuals with AD dementia in the same age group. This finding is particularly striking, as it suggests that the super ager phenotype can identify a group of oldest adults with a reduced genetic risk for Alzheimer's disease.
But that's not all. Super agers were also found to have a higher frequency of the protective APOE-ε2 variant. They were 28% more likely to carry APOE-ε2 than cognitively normal controls aged 80 and above, and an astonishing 103% more likely than participants with AD dementia in the same age range.
The study, which included the largest sample of super agers to date, analyzed data from the Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium. It involved 18,080 participants from eight national aging cohorts, making it a comprehensive and statistically powerful investigation.
Super-ager status was determined by comparing memory performance among individuals aged 80 and older with those of cognitively normal participants aged 50 to 64. The study included diverse race/ethnicity groups, adding to its broad applicability.
As the interest in super agers grows, this research encourages the idea that the super-ager phenotype could be a valuable tool in understanding the mechanisms that confer resilience against Alzheimer's disease. The findings highlight the potential of genetic variants, such as APOE-ε4 and APOE-ε2, in influencing the development of clinical dementia due to Alzheimer's.
The study's authors, including Leslie Gaynor, Alaina Durant, and Timothy Hohman, emphasize the importance of further research in this field. They invite discussions and encourage readers to explore the potential implications of these genetic variations in the context of super agers and Alzheimer's disease.
